Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-02-02T12:06:44.012Z Has data issue: false hasContentIssue false
  • English
  • Français

Heterogeneity in Multiple Sclerosis: Comparison of Clinical Manifestations in Relatives

Published online by Cambridge University Press:  18 September 2015

A.D. Sadovnick ,
L.L. Hashimoto  and
S.A. Hashimoto
A.D. Sadovnick*
Affiliation:
Department of Medical Genetics, University of British Columbia, Vancouver Multiple Sclerosis Clinic, University Hospital-UBC Site, University of British Columbia, Vancouver
L.L. Hashimoto
Affiliation:
Department of Medical Genetics, University of British Columbia, Vancouver
S.A. Hashimoto
Affiliation:
Multiple Sclerosis Clinic, University Hospital-UBC Site, University of British Columbia, Vancouver
*
Dept. of Medical Genetics, University of British Columbia, 6174 University Boulevard, Vancouver, British Columbia, Canada V6T 1W5
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Once diagnosed to have MS, relatives of persons who have been previously diagnosed frequently ask whether their disease course will follow that of their relative(s) with MS. The present study compared the following clinical manifestations of MS among 43 index cases and 47 of their relatives, all of whom were diagnosed to have MS and regularly attended the MS Clinic in Vancouver, British Columbia: (i) age of onset of MS, (ii) clinical course, (iii) lesion site(s) and (iv) initial symptom(s) of MS. The results from the present study are preliminary because of the small size of the study group. However, these data suggest that apart from possibly age of onset between sibling pairs, the clinical manifestations of MS are not correlated among relatives who are assessed according to the same methodology. This is significant for counselling newly diagnosed relatives of longstanding MS patients.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 17 , Issue 4 , November 1990 , pp. 387 - 390
Copyright
Copyright © Canadian Neurological Sciences Federation 1990

References

REFERENCES

1.Sadovnick, AD, Baird, PA, Fabro, S. The familial nature of multiple sclerosis: age-corrected empiric risks for children and siblings of patients Neurology 1988; 38: 990–991.CrossRefGoogle ScholarPubMed
2.Sadovnick, AD, Baird, PA, Ward, RH. Multiple sclerosis: updated risks. Am J Med Genet 1988; 29: 533–541.Google ScholarPubMed
3.Ebers, GC, Bulman, DE, Sadovnick, AD, et al. A population based twin study in multiple sclerosis. N Engl J Med 1986; 315: 1638–1642.CrossRefGoogle Scholar
4.Kurtzke, JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.Google Scholar
5.Schumacher, GA, Beebe, G, Kibler, RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report of the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965; 122: 552–568.Google Scholar
6.Poser, CM, Paty, DW, Scheinberg, L, et al. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. In: Poser, CM, Paty, DW, Scheinberg, L, Ebers, GC, eds. The Diagnosis of Multiple Sclerosis. New York: Thieme-Stratton 1984; 225–229.Google Scholar
7.Weinshenker, B, Bass, B, Rice, GPA, et al. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 1989; 112: 133–146.Google ScholarPubMed
8.Bulman, DE, Sadovnick, AD, Cripps, J, et al. Age of onset in siblings concordant for multiple sclerosis. (Submitted.) Summary in Gonatas, NK, Greene, MI, Waksman, BH. Genetic and Molecular Aspects of Demyelination. Immunology Today 1986; 7: 121–126.Google Scholar
9.Weinshenker, B, Armstrong, H, Bulman, D, et al. A comparison of familial and sporadic MS. Can J Neurol Sci 1986; 13 (Abstract): 168.Google Scholar
10.Schapira, K, Poskanzer, DC, Miller, H. Familial and conjugal multiple sclerosis. Brain 1963; 86: 315–332.CrossRefGoogle ScholarPubMed
11.Kurtzke, JF. Epidemiological contribution to MS: an overview. Neurology 1980; 30: 61–79.CrossRefGoogle Scholar
12.Kurtzke, JF, Hyllested, K. Multiple sclerosis in the Faroe Islands: 1. Clinical and epidemiological features. Ann Neurol 1979; 5: 621.CrossRefGoogle ScholarPubMed
13.Harper, PS. Myotonic dystrophy. Philadelphia: WB Saunders 1979; 10: 219–223.Google Scholar
14.Kurtzke, JF. On the evaluation of disability in multiple sclerosis. Neurology 1961; 11: 686–694.CrossRefGoogle ScholarPubMed